New York, New York – Newsfile Corp. – April 15, 2023 – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Ascendis Pharma (NASDAQ: ASND) resulting from allegations that Ascendis may have issued materially misleading business information to…Read More
ROSEN TRUSTED INVESTOR COUNSEL Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation ASND Taiwan News 20230415 225000
